India sticks to AstraZeneca vaccine ‘with full vigour’
Al Jazeera
Government expert says India’s health ministry is aware of potential blood clot issue but he had ‘no concern at all’.
India is not worried about some European Union countries suspending use of the AstraZeneca COVID-19 vaccine and will continue to roll out the shot in its huge immunisation programme “with full vigour”, a senior official said. The AstraZeneca shots are produced by India’s Serum Institute and known in the country as Covishield. The vaccine accounts for most of the 35 million coronavirus jabs administered in the country so far. But the European nations, including France, Spain and Germany, have suspended the vaccine’s use because of worries it causes blood clots.
Immigrant rights groups fear harsh policies and potential legal pressure could accelerate in second Trump term.
Small islands and least-developed nations say their climate finance interests were ignored.
Global lender says it will release about $333m to crisis-hit nation as signs of economic recovery emerge.
At least four people have been killed in the attack on the Basta neighbourhood, according to the Health Ministry.
A series of unexplained incidents causing damage to pipelines and cables in the Baltic Sea has occurred in the past two years. Could this be a new form of underwater warfare?
The hedge fund manager will be responsible for implementing president-elect’s pledges to cut taxes and raise tariffs.
Cola Gaza offers its drinkers an ‘apartheid-free’ alternative as they boycott big-name brands.
These were the key developments on the 1,003rd day of the Russia-Ukraine war.
Defectors from Myanmar’s military and police are learning skills that could put them on a new path after years of war.
World Health Organization says 226 health workers, patients killed in Lebanon since start of Israel’s war on Hezbollah.